Efavirenz
- Product NDC
- 64380-889
- 11-digit product format
- 643800889
- Labeler code
- 64380
- Product ID
- 64380-889_cb9a4342-375f-4b47-bdf3-97c1fd8951c6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Efavirenz
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Strides Pharma Science Limited
- Application
- ANDA204869
- Marketing category
- ANDA
- Marketing start
- 2018-03-29
- Marketing end
- 0000-00-00
- Substance
- EFAVIRENZ
- Active strength
- 600 mg/1
- Pharmacologic classes
- Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 64380-889-04 | 64380088904 | 30 TABLET in 1 BOTTLE (64380-889-04) | 30 tablet | 2018-03-29 | 0000-00-00 | No | No | Current |